Gilles Weder (Head Research & BD) is Head of Research & Business Development at CSEM Life Sciences, where he drives the development and transfer of cutting-edge innovations to the life sciences industry. He defines strategic roadmaps for cell microsystems and biomonitoring, with applications in drug screening, diagnostics, and regenerative medicine. His expertise includes complex 3D in vitro models, single-cell technologies, lab automation, biosensing, contactless sensing, and artificial intelligence. Through Bioconvergence & TechBio — where biotech, engineering, and computing intersect — Gilles Weder accelerates transformation for clients and partners.
This website uses cookies so that we can give you the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team understand which sections of the website you find most interesting and useful.
For more information, visit our privacy policy page


